Clinical Trial

Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery

Study acronym: POLYNOVO-CHD
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to elucidate, if the colonization of bacteria is lower on the Novosyn® CHD suture compared to uncoated Polyglactin 910 suture, which will be assessed by the incidence of surgical site infections (SSI: A1 and A2). The results of this registry will generate further clinical evidence for the use and the benefit of a Chlorhexidine coated suture used to close the wound after an emergency or elective laparoscopic or laparotomy surgery. The benefit for individual patients lies in the early diagnosis of complications and in the optimized postoperative controls of a clinical study.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-07-28; most recent amendment 2026-03-05.
Status change: Not Yet Recruiting → Recruiting 2023-09-28
Trial Details
NCT Number NCT05966961
Lead Sponsor Aesculap AG
Collaborators: B.Braun Surgical SA
Conditions Surgical Site Infection
Enrollment 2,998 participants
Start Date 2023-09-18
Primary Completion 2028-08 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-06